Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-005890
Filing Date
2021-01-20
Accepted
2021-01-20 17:00:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm213363-4_424b5.htm 424B5 569817
2 GRAPHIC aclaristmfpo-4c_logo.jpg GRAPHIC 11529
3 GRAPHIC tm213363d1-fc_company4clr.jpg GRAPHIC 91572
  Complete submission text file 0001104659-21-005890.txt   713094
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237163 | Film No.: 21539376
SIC: 2834 Pharmaceutical Preparations